₹ 1513.5
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Bharat Parenterals Limited specializes in the development and production of pharmaceutical formulations, offering a broad spectrum of products. Their diverse portfolio encompasses general-purpose medicines, B-Lactam compounds, cephalosporin-based drugs, anti-retroviral therapies, and veterinary pharmaceuticals. This company was established by Ramesh Desai on September 3, 1992, and operates from its main office situated in Vadodara, India.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is 'expensive' on EV/EBITDA.
Data is available to registered users only